NCT03449030: A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) |
|
|
| Terminated | 1 | 31 | US | TAK-164, 89Zr-TAK-164 | Millennium Pharmaceuticals, Inc. | Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies | 02/20 | 02/20 | | |
